CAMBRIDGE, UK--(Marketwire - October 30, 2007) - Serentis, a UK-based biopharmaceutical company innovating, acquiring and developing dermatological and wound care products, announces today that it has appointed Peter Keen as Corporate Development and Finance Director.
